Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
July 04, 2021 at 16:47 PM EDT
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P 500 Index.